این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
پنجشنبه 20 آذر 1404
Archives of Breast Cancer
، جلد ۱۲، شماره ۳، صفحات ۰-۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
The Impact of the COVID-19 Pandemic on Attendance and Diagnostic Outcomes at Breast Screen Western Sydney, Australia: Impact of COVID-19 on breast screen
چکیده انگلیسی مقاله
Background: BreastScreen, Australia’s population screening program, was disrupted by the COVID-19 pandemic. This study examined the pandemic’s effect on attendance and assessment outcome data to inform service planning for the recovery period. Methods: BreastScreen Western Sydney data from ‘pre-COVID’ (2018 and 2019) versus ‘COVID-affected’ years (2020 and 2021) were analyzed. The number of screens, recall rate, sociodemographic data of clients, and imaging and pathological features of malignancies were also analyzed. Results: During the four-year study period, COVID-affected years demonstrated an 18.8% reduction in screening episodes (77 510 vs 95 467, P < 0.001) and a 16.3% reduction in malignancies (512 vs 612, P = 0.49) compared to pre-COVID years. The cancer detection rate (cancers detected per 10 000 screens) remained similar (52.8 vs 52.3 per 10 000 screens for invasive cancer, P = 0.89 and 66.1 vs 64.1 for all malignancies, P = 0.62), and the recall rate was lower (4.2% vs 4.8%, P < 0.001). Younger women and first-time screeners were less likely to attend during COVID-19. There was no significant difference in the proportion of ductal carcinoma in situ (DCIS) vs invasive cancers (20.1% vs 18.5%, P = 0.48), the mean invasive tumor size (18.7 mm vs 17.8 mm, P = 0.37), or the size of DCIS (46.4 mm vs 21.8 mm, P = 0.11) between COVID-affected and pre-COVID years. Conclusion: There was an expected reduction in the number of screens and cancers detected during COVID-19, without a change in tumor size or cancer detection rate. Younger women should be targeted for catch-up screening. Services should plan for the 19% of the screening cohort that failed to attend during the pandemic, as they may present with later-stage cancers.
کلیدواژههای انگلیسی مقاله
breast neoplasm, early diagnosis of cancer, cancer screening, COVID 19, health, public
نویسندگان مقاله
نشانی اینترنتی
https://archbreastcancer.com/index.php/abc/article/view/1105
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
10.32768/abc.1689666873857
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Original Article
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات